Preoperative fructosamine is comparable to HbA1c as a short-term glycemic marker for predicting postoperative complications in orthopaedic surgery: A systematic review and meta-analysis

Key Points

• Fructosamine is a reliable glycemic marker for predicting postoperative complications in orthopaedic surgery, similar to HbA1c.
• The analysis includes 15 studies and suggests that using fructosamine could positively impact patient outcomes during recovery.
• Systematic review and meta-analysis conducted to compare glycemic markers and their association with postoperative complications.
• Significant implications for preoperative assessments, supporting fructosamine as an alternative to HbA1c in orthopaedic surgery.